QUADRANT CAPITAL GROUP LLC - IOVANCE BIOTHERAPEUTICS INC ownership

IOVANCE BIOTHERAPEUTICS INC's ticker is IOVA and the CUSIP is 462260100. A total of 242 filers reported holding IOVANCE BIOTHERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 0.18 and the average weighting 0.1%.

Quarter-by-quarter ownership
QUADRANT CAPITAL GROUP LLC ownership history of IOVANCE BIOTHERAPEUTICS INC
ValueSharesWeighting
Q2 2024$40,574
-45.9%
5,0590.0%0.00%
-50.0%
Q1 2024$74,975
+82.3%
5,0590.0%0.01%
+50.0%
Q4 2023$41,130
+2272.0%
5,059
+1227.8%
0.00%
Q3 2023$1,734
-86.4%
381
-79.0%
0.00%
-100.0%
Q2 2023$12,771
+24.1%
1,814
+7.7%
0.00%0.0%
Q1 2023$10,290
-4.4%
1,6840.0%0.00%0.0%
Q4 2022$10,761
+976.1%
1,684
+1175.8%
0.00%
Q3 2022$1,000
-66.7%
132
-49.0%
0.00%
Q2 2022$3,000
-25.0%
259
-7.8%
0.00%
Q1 2022$4,000
-78.9%
281
-72.4%
0.00%
-100.0%
Q4 2021$19,0000.0%1,017
+31.6%
0.00%
-33.3%
Q3 2021$19,000
+216.7%
773
+239.0%
0.00%
+200.0%
Q2 2021$6,000
+200.0%
228
+240.3%
0.00%
Q1 2021$2,000
-33.3%
67
+3.1%
0.00%
-100.0%
Q4 2020$3,000
+200.0%
65
+91.2%
0.00%
Q3 2020$1,000
-75.0%
34
-77.3%
0.00%
-100.0%
Q1 2020$4,0001500.00%
Other shareholders
IOVANCE BIOTHERAPEUTICS INC shareholders Q3 2022
NameSharesValueWeighting ↓
ACUTA CAPITAL PARTNERS, LLC 3,019,201$26,720,00020.38%
Broadfin Capital, LLC 5,951,153$52,668,0006.92%
GREAT POINT PARTNERS LLC 5,567,348$49,271,0006.23%
Avoro Capital Advisors LLC 10,261,039$90,810,0005.43%
FRAZIER MANAGEMENT LLC 2,188,331$19,367,0005.00%
Prosight Management, LP 1,062,500$9,403,0004.85%
Perceptive Advisors 12,241,111$108,333,0004.12%
Ghost Tree Capital, LLC 1,000,000$8,850,0003.21%
QVT Financial LP 1,021,361$8,696,0002.84%
Vivo Capital, LLC 1,600,000$14,160,0001.81%
View complete list of IOVANCE BIOTHERAPEUTICS INC shareholders